Oragenics
OGEN
16 hedge funds and large institutions have $5.67M invested in Oragenics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
6% less funds holding
Funds holding: 17 → 16 (-1)
9% less capital invested
Capital invested by funds: $6.22M → $5.67M (-$546K)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$494K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$238K |
| 3 |
VF
Virtu Financial
New York
|
+$238K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$46.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$56K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$25.6K |
| 3 |
GPFA
Game Plan Financial Advisors
Westlake,
Ohio
|
-$7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$6K |
OGEN Hedge Fund Activity: Q3 2020 in Review
16 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2020, worth a combined $5.67M — down 8.8% from $6.22M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of OGEN and 4 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $494K. The largest seller was Integrated Wealth Concepts, exiting entirely with an estimated $56K sold.
- 16 institutional investors held Oragenics (OGEN) as of Q3 2020, down from 17 in Q2 2020.
- Funds reported $5.67M of Oragenics stock for Q3 2020, down 8.8% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q3 2020 and 5 closed out, a net change of -1 holder.
- The largest Oragenics buyer in Q3 2020 was Renaissance Technologies, an estimated $494K added.
- The largest Oragenics seller in Q3 2020 was Integrated Wealth Concepts, an estimated $56K sold.
Based on aggregated 13F filings for Q3 2020.